Saniona APS
Records under this name other than patents Saniona APS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Saniona APS
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,387,184 | Pharmaceutical compositions for combination therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,931,329 | Phenyl triazole derivative and its use for modulating the GABAA receptor complex Formerly held Lapsed on the fee record Ended Apr 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2026 | From the USPTO record |
| US 8,501,777 | 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission Lapsed on the fee record Ended Aug 6, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 6, 2025 | From the USPTO record |
| US 7,763,639 | Disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission Term ended Term ended Jun 8, 2025 · From the USPTO record | Term ended | Term ended Jun 8, 2025 | From the USPTO record |
| US 9,457,018 | Method for combating adverse effects arising from antipsychotic treatment Formerly held Lapsed on the fee record Ended Oct 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2024 | From the USPTO record |
| US 9,206,160 | Phenyl triazole derivative and its use for modulating the GABAA receptor complex Formerly held Lapsed on the fee record Ended Dec 8, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2023 | From the USPTO record |
| US 8,017,631 | Oxadiazole derivatives and their medical use Lapsed on the fee record Ended Sep 13, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2023 | From the USPTO record |
| US RE41,315 | Modulators of dopamine neurotransmission Term ended Term ended Dec 22, 2020 · From the USPTO record | Term ended | Term ended Dec 22, 2020 | From the USPTO record |
| US 8,314,126 | Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission Lapsed on the fee record Ended Nov 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2020 | From the USPTO record |